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ABSTRACT  The effects of tetracaine on charge movements and on antipyrylazo 
III signals monitoring intracellular &[Ca  ~§  were compared in cut frog semitendi- 
nosus muscle fibers in a single vaseline gap-voltage clamp. Low tetracaine concen- 
trations (25-40 #M) markedly reduced A[Ca  ~+] signals and shifted the rheobase. 
However, they neither influenced charge movement nor that peak A[Ca  ~+] value 
associated with the contractile threshold.  Higher tetracaine concentrations (100- 
200 #M) partly inhibited charge movements in cut fibers. They separated a steeply 
voltage-sensitive charge, some of whose features resembled 'q~' reported in intact 
fibers,  and whose movement preceded A[Ca  ~§  signals at threshold.  These find- 
ings: (a) directly confirm an earlier suggestion that tetracaine acts on steps in exci- 
tation-contraction coupling rather than myofilament activation; (b) show that tetra- 
caine  at  low  concentrations  can  directly  interfere  with  sarcoplasmic  reticular 
calcium release without modifying charge movement; (c) show that the tetracaine- 
sensitive charge, first found in intact fibers, also exists in cut fibers; and (d) make it 
unlikely that tetracaine-sensitive charge transfer is a consequence of Ca  2+ release 
as suggested on earlier occasions. 
INTRODUCTION 
A number of apparently differing reports exist on the actions of tetracaine on skel- 
etal muscle charge movements. Almers (1976)  successfully suppressed contraction 
even when  neither  the  nonlinear  charge  nor  the  contractile  response  of skinned 
fibers to applied Ca  ~§  was significantly altered (Almers and Best,  1976).  This sug- 
gested  that  there  were  effects on  excitation-contraction  coupling  stages  that  fol- 
lowed any required charge movement, but preceded myofilament activation. On this 
basis, tetracaine has been used to immobilize mammalian muscle when studying its 
charge movements, which,  at that time, were assumed not  to be affected by such 
pharmacological treatment (e.g., Dulhunty and Gage, 1983; Dulhunty et al.,  1987). 
However, in contrasting findings,  tetracaine removed as much as one-third of the 
nonlinear  charge,  and  particularly  reduced  the  delayed  ('q~')  transients  obtained 
near the contractile threshold (Huang, 1981).  Indeed, use of tetracaine, dantrolene 
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sodium, or prolonged depolarization all separated a capacitance whose steep depen- 
dence upon voltage resembled that of tension generation (Huang,  1982; Hui,  1983) 
or of A[Ca  ~+]  signals  (Vergara  and  Caputo,  1983).  However,  the  reasons  for the 
apparent  discrepancies between the  two  sets of results have  not been  investigated 
further. 
The  present  experiments  explore  whether  tetracaine  could  have  two  sites  of 
action in the excitation-contraction coupling sequence. If Ca  ~+ release from the sar- 
coplasmic reticulum were the more sensitive step, then contractile activity could be 
suppressed before  the  charge  movement  was  altered  (cf.,  Almers,  1976).  In  con- 
trast, greater drug concentrations could then influence both charge movement and 
calcium  release.  Charge  movements,  intracellular A[Ca2+],  and  contractile activity 
were therefore simultaneously measured in cut fibers to which antipyrylazo III was 
added from the open end. 
METHODS 
Single fibers from frog (Ram esculenta)  semitendinosus muscle were mounted in a single vas- 
eline-gap voltage clamp (Kovacs and Schneider,  1978;  Kovacs and Szucs, 1983). The closed 
segment in the pool that contained external solution was fixed by its tendon and stretched 
such that the length of its sarcomeres was between 2.4 and 3.0 #m. The length of this closed 
segment was between 355  and 543 #m and that under the vaseline seal was 200-600  #m. 
Fiber diameters ranged  from  77  to  120  /~m, and experiments were performed at 4-60C. 
Fibers were dissected in a Ringer solution (115 mM NaC1, 2.5 mM KC1, 1.8 mM CaCI~, 2 mM 
Tris maieate buffer) and cut in a relaxing solution (120 mM K glutamate, 2 mM MgC1  v  0.1 
mM EGTA, 5 mM Tris sodium maleate buffer) before they were mounted in the experimen- 
tal chamber. The external solution consisted of 75 mM tetraethylammonlum sulfate, 10 mM 
Cs~SO4, 8 mM CaSO4, 3  x  10 -7 M tetrodotoxin; and 5 mM "Iris sodium maleate buffer. The 
internal solution contained  105  mM Cs glutamate, 5.5 mM MgCI~, 0.1  mM  EGTA, 0.0082 
mM CaCI2, 4.5 mM Tris sodium maleate buffer, 13.2 mM Tris Cs maleate buffer, 5 mM ATP, 
and  5.6  mM  glucose.  Further details of experimental procedures are available elsewhere 
(Csernoch et al., 1987). 
Antipyrylazo III, at a  concentration of 0.5-1  mM in the open-end pool, was allowed to 
diffuse into the intracellular space of the voltage-clamped fiber segment. Changes in intracel- 
lular [Ca  ~+] that resulted from depolarizing pulses were calculated from dye concentrations 
and absorbances at wavelengths of 720 and 850 run as described by Csernoch et al. (1987). A 
K D of 1.76  x  10 -s M ~ at a  [Mg  a+] of 1 mM, and an extinction coefficient of 8.2  x  103 M -] 
cm -]  at  a  720-nm  wavelength  were  assumed.  When  alternative  values  were  assumed 
(K  D = 35,100 #M  2, extinction coefficient -  1.5 x  104 M -~ cm -]) 2:1 dye: Ca  2+ stoichiometry 
(200C;  Hollingworth et al., 1986) did not lead to large divergences. Thus, as seen in Fig. 1, 
using the latter values altered peak A[Ca  ~+] by only 8.7% in controls, and 6.1 and 6.5% in 25 
laM tetracaine, and then in the same positive direction. 
Charge movement records were simultaneously obtained by comparing capacity currents 
resulting from depolarizing (tes0 pulses of 100- or 60-ms duration, with those from 30-mV 
hyperpolarizing (control) pulses from the -  100-mV holding potential scaled by the ratio of 
the respective voltage excursions. Unless otherwise stated, each control or test record was the 
average of 12 sweeps. The control sweeps bracketted the test sweeps and, together with mon- 
itoring holding current, checked fiber stability and condition. Linear capacitances deduced 
from such pulses are provided in the figure legends. When investigating the effect of tetra- 
caine, the above procedures were performed both before and after adding the drug. Tetra- 
caine-sensitive charge movement was  then  isolated by comparing records obtained in  the CSZRNOCH ET AL.  Differential  Effects of Taracaine  603 
presence and absence of pharmacological agent, after correction for linear transients. In such 
experiments, linear capacitances in runs before and after adding tetracaine were compared to 
assess  preparation stability.  In eight fibers, the ratio of linear capacitances before and after 
adding 200 #M tetracaine was  1.0  +  0.03  (mean •  SE).  Contractile thresholds were deter- 
mined by using 100-ms long depolarizing pulses of graded (1-2 mV) amplitude and by look- 
ing for mechanical activity through a  40  X  water  immersion objective  (see  Kovacs et  al., 
1987). 
When investigating the quantity and late time course of tetracaine-sensitive charges to com- 
pare them with A[Ca  *+] signals (see Figs. 5 and 6), high-frequency noise was digitally filtered 
within  each pulse  interval.  The computational procedure  fitted  successive sets of 10 data 
points  to a  second-order  polynomial through  a  least-squares  procedure,  as  described  by 
Guest (1961).  The method choice was checked by comparing the peak values and integrals 
derived from the filtering with those of the original data. Apart from a smoothing at early 
times, this gave a clearer representation of the time course of charge movements particularly 
around their peak values. 
RESULTS 
Selective Effects on A[Ca  2§  Signals 
Fig.  1 A  illustrates  how different tetracaine concentrations affect A[Ca  2§  transients 
at the normal fiber threshold voltage, which was determined before local anesthetic 
was  added.  Calcium  transients  and  charge  movements  were  first  obtained  at  the 
rheobase, which was determined in the absence of local anesthetic.  Next, tetracaine 
(25 #M) was added to the extracellular pool and the new rheohase was determined. 
A[Ca  l+]  transients  were  then  obtained  at  voltages  that  corresponded  to  these 
respective old and new (Fig.  1 B) rheobases in the presence of 25, 40, and 200 ~aM 
tetracaine.  Where possible,  the contractile threshold was also evaluated at all these 
concentrations.  In addition,  charge  movements were explored over a  wide voltage 
range in the same fiber when tetracaine levels were 0 and 40 ~M. This experimental 
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FIGURE  1.  Ca  ~+  transients  at 
(A)  the  normal  rheobase 
(-49.1  mV) determined in the 
absence of drug, and (B) at the 
rheobase  (-34  mV)  as  deter- 
mined  in 25  ~M  tetracaine  at 
progressively  increasing  tetra- 
caine concentrations (0, 25, 40 
and 200/zM). Fiber 1212: fiber 
diameter,  190  #m;  linear 
capacitance,  6.48  nF;  sarco- 
mere  spacing,  2.24  ~m;  tem- 
perature,  5.5~  Intracellular 
antipyrylazo  III  concentra- 
tions: control trace, 320/~M; in 
25  /~M  tetracaine,  470-545 
gM; in 40/~M tetracaine, 770- 
830 #M; and in 200 ~M tetra- 
caine, 950 ~tM. 604  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY. VOLUME  92.  1988 
design gave us the following interrelated findings: (a) A[Ca  2+] transients at two volt- 
ages over a range of tetracaine concentrations; (b) the influence of tetracalne on the 
contraction  threshold;  (c) whether  there was  a  tetracaine concentration at which 
A[Ca  ~+]  signals  were  reduced despite  the  nonlinear  charge  remaining intact;  (d) 
A[Ca  2+] transients at voltages where mechanical activity was just observable, in both 
the  presence and  absence of tetracaine;  (e) charge movements both at old (0 #M 
tetracaine) and new (25 #M tetracaine) thresholds; and (f) charge movements in the 
presence and absence of tetracaine over a wide voltage range. 
Our  use  of the  single gap  at  the end  of the  fiber thus  allowed us  to examine 
contractile threshold and charge movements simultaneously, the latter often over a 
wide voltage range.  In the preparations reported, the contractile rheobase did not 
change more than 2-3 mV during an experimental run conducted in the absence of 
tetracaine.  However, we could examine A[Ca  2+]  transients  only before or around 
rheobase, where contractile activity was weak and developed only towards the end of 
the  pulse.  Intrinsic  (A = 850  nm)  signals  were  then  additionally  monitored  to 
exclude mechanical  optical  artifacts.  Such  artifacts occurred in  experiments  that 
demanded large  depolarizations  (see below), when,  for this  reason,  only capacity 
transients could be investigated. 
Changes in rheobase. Tetracaine (25 ~M) significantly shifted the rheobase from 
-42.4  _+  3.32 mV (mean + SE; seven fibers) to  -29.7  +  2.5 mV. Tetracaine at 40 
#M prevented contraction even with voltage steps to positive potentials. This sug- 
gests a  more profound effect on contractile activation in cut fibers than in intact 
muscle where millimolar concentrations were used (Almers and Best,  1976). 
Changes in A[Ca  2+] transients. These were depressed with increasing tetracaine 
concentration at both voltages examined (Fig. 1 A and B). Peak A[Ca  ~+] in the seven 
fibers  studied  at  the  normal  threshold  was  1.9  _+  0.15  t~M  when  tetracaine  was 
absent.  At  the  same  testing voltage, even 25 #M  tetracaine reduced this  peak by 
44 _+ 4.3% and 40 #M reduced it by 80%.  Finally, adding 200 #M tetracaine com- 
pletely abolished A[Ca  ~+] signals. 
Peak ~l[Ca  2+] associated with the onset of  contraction. This could be determined for 
tetracaine concentrations of 0 and 25 #M only; even at 40 #M, mechanical activity 
was completely suppressed even with large (> 100 mV) voltage steps. A voltage step 
to the rheobase produced a  peak A[Ca  2+]  of 1.9  _  0.15 #M  (seven fibers) before 
local  anesthetic  was  added.  Adding  25  #M  tetracalne  shifted  the  rheobase  (see 
above), but the peak A[Ca2+],  once contractile threshold was reached with a larger 
voltage step, did not change more than 6.7  _  1.2% in any given fiber. This suggests 
that  the  same  value of peak  A[Ca  ~+]  corresponded  to  the  onset  of contraction, 
which is in agreement with findings of Kovacs and Szucs (1983). Changes in intracel- 
lular antipyrylazo III concentrations through times before and after adding 25 #M 
tetracaine (between 470 and 545 ~M in Figs. 1 and 2) would not affect our interpre- 
tation of free A[Ca  2+] from antipyrylazo III absorbances in these experiments (Ko- 
vacs et al.,  1983). 
Relation between nonlinear charge and &[Ca2+]. Fig. 2 A compares charge move- 
ment and A[Ca  ~+]  signals in response to threshold voltage steps before tetracaine 
was added,  at early times immediately after the voltage steps were imposed.  Such 
voltage steps moved 14.9  _+ 2.2 nC/#F (four fibers) of nonlinear 'threshold' charge CSERNOCH ET AL.  Differential Effects of Tetracaine  605 
(cf.,  Horowicz and Schneider,  1981). The same voltage steps moved similar charge 
(15.0  ___ 2.05 nC/~F) in 25 #M tetracaine, even though A[Ca  2§  signals were reduced 
(peak A[Ca  2§  changed from 2.0 to 1.25 uM in Fig.  2 B), and contraction was sup- 
pressed. To elicit contraction in 25 ~M tetracaine required larger voltage steps. The 
latter then elicited a peak A[Ca  2+]  similar to those obtained before  the addition of 
tetracaine (1.9 #M; compare  Fig.  2 A  and C). However, such larger depolarizations 
moved  a  larger  nonlinear charge  of  19.1  +_  1.9  nC/~F.  Hence,  although  25  ~M 
tetracaine did not alter charge movement,  it increased the charge transfer required 
to achieve a particular peak A[Ca2+]. 
Effects  on  charge  movement.  Noticeable  effects  on  A[Ca  2+]  signals  were  thus 
observed  with  25  #M  tetracaine  and  there were  large  effects  at  40  #M.  This was 
despite little or no significant change in the charge movement at the threshold volt- 
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FIGURE 2.  Comparison of charge movements and Ca  ~+ transients  at (A) the normal rheo- 
base (-49 mV), (B) at the  same voltage,  and  (C)  at the  new threshold  (-34 mV) in  25  tiM 
tetracaine.  A  faster timebase  than in Fig.  1  was chosen  to emphasize  early events.  (A and B) 
Charge movements whether in 0  or 25 #M tetracaine similar at -49  mV despite reductions in 
peak A[Ca2+]. (C) Similar peak  A[Ca  z+] associated  with the onset of contractile  activation  at 
-34  mV in tetracaine despite increased  nonlinear charge  transfer.  Fiber 1212, as in Fig.  1. 
age, which was determined  at the outset of the experiments.  We then investigated 
charge movements  over a wider voltage range in three fibers at both 0  and 40 vM 
tetracaine. In these experiments, the pulse durations were shortened at larger depo- 
larizations, the closed segment was left slack to minimize contraction artifacts in the 
electrical  traces,  and  linear  capacitance  was  monitored  in  runs  before  and  after 
tetracaine was added.  However,  this arrangement permitted mechanical artifacts to 
appear in optical traces and so precluded the measurement  of A[Ca 2+] signals.  Fig. 
4  (legend) indicates linear capacitance  decreased by not >3% through the two sets 
of readings.  In any case, values of maximum charge were expressed per unit linear 
membrane capacitance. The charge movements were similar under both conditions 
in both amplitude and time course  (Fig.  3). Tetracaine did not alter the maximum 606  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY.  VOLUME  92.  1988 
charge (Qm~,) by more than  -3.3  _+  1.9% and Q.~  values obtained by large (100 
mV) depolarization (23.3 _+ 4.42 nC/#F) agreed with earlier reports (Schneider and 
Chandler,  1973). Charge-voltage curves (Fig.  4) were normalized to Q~,.~ values and 
then described by a  two-state Boltzmann function. These yielded similar steepness 
factors (k)(controls: k =  13.6 +- 1.1  mV; tetracaine added: k =  13.7 _+ 1.32 mV) and 
transition voltages (V =  -46.9 -+ 1.9 and -49.9 +_ 2.3 mV, respectively) in the pres- 
ence (filled  symbols) and absence (open symbols) of tetracaine. 
Low tetracaine  concentrations thus noticeably affected calcium signals and con- 
tractile activation. However, they did not significantly influence charge movements 
nor the relationship between peak A[Ca  ~+] and the contractile threshold. 
Tetracaine-sensitive Charge Does Exist in Cut Fibers 
Tetracaine-sensitive  ('qv') charge is  associated with  delayed transients  and  'hump' 
phases close to the contractile threshold in intact fibers (Huang,  1981,  1982; Hui, 
FIGURE 3.  Charge  move- 
ments  over  a  wide  voltage 
range (A) in 0 #M and (B) 40 
#M tetracalne  compared in the 
same fiber. Fiber 1210: diame- 
ter,  81.4  Urn; sarcomere spac- 
ing,  2.5  #m;  temperature, 
5.4"C. Currents normalized to 
the  linear  fiber  capacitance, 
which was 6.56  -+ 0.058 nF in 
the  run  before tetracaine  was 
added,  and  6.30-+ 0.036  nF 
after  tetracaine  was  added. 
Values of Qm~ were 37.61 and 
36.98  nC/oF  (normalized  to 
the  respective  linear  capaci- 
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tances),  V values were  -43.85 and  -46.58 mV, and k values were  14.62  and  14.66  mV 
before and after adding tetracalne,  respectively. 
1983; Adrian and Huang,  1984a, b).  However, such slow currents were frequendy 
less  distinguishable  or even  absent  both  in  the  cut  fibers  observed here,  and  on 
earlier  occasions  (Melzer  et  al.,  1986b).  We  therefore  investigated  whether  such 
components  exist,  at  least  as  tetracaine-sensitive  charge  in  cut  fibers,  by  trying 
higher tetracaine concentrations. However, the concentrations of the order of 2-4 
mM used on intact fibers were rapidly toxic to cut fibers, which deteriorated even at 
400-#M levels.  Similar findings have been reported in cut mammalian fibers (Lamb, 
1986). 
The effect of tetracaine was consequently studied only up to 100-200 #M at volt- 
ages around the normal contraction threshold in seven fibers. It was therefore pos- 
sible that the tetracaine-sensitive charge was not entirely suppressed. 
Nevertheless, we could still  estimate lower limits for its quantity and obtain indi- 
cations of its time course and voltage sensitivity. Additionally (see below) the amount 
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FIGURE 4.  Steady  state  nor- 
malized  charge-voltage  curves 
in  (A)  0  gM  (open  symbols) 
and  (B)  40  #M  tetracaine 
(filled symbols) studied  in  the 
same  fiber  for  three  fibers. 
The line corresponds to a two- 
state  Boltzmann  model  fitted 
to data in the absence of tetra- 
caine.  Fiber  capacitances: 
7.3 _+ 1.31 and 7.1  +  1.22 nF 
before and after adding tetra- 
caine, respectively. 
tetracaine concentration was increased from 100 to 200 #M, which suggests that a 
maximal effect was already reached at  100 #M tetracaine under the present condi- 
tions.  The  experiments  first  determined  the  contractile  threshold.  Voltage  steps 
were then made to this membrane potential, and to levels 5 mV on either side of it. 
Tetracaine  (200  #M)  was  then  added  and  the  procedure  was  repeated.  Charge 
movements and  [Ca  2+]  transients  were recorded simultaneously.  Tetracaine-sensi- 
tive charge movement was determined by comparing records before and after tetra- 
caine was added. There was no significant change (<1.6%, P  >  5%) in linear capaci- 
tances before (7.2 +_ 0.84 nF) and after (7.08 _+ 0.92 nF) the drug was added. This 
procedure suggested that 100 and 200 #M tetracaine isolated 2.77 + 0.37 and 2.8 _+ 
0.98  nC/vF  (mean_ SE;  seven  fibers  studied)  of  'threshold'  nonlinear  charge, 
respectively. 
Fig.  5  compares tetracaine-sensitive  'on' currents  (arrowed traces) with  A[Ca  2+] 
transients.  It confirms that  tetracaine-sensitive  charge  exists  in  cut  fibers  as  sug- 
reported in intact fibers (Adrian and Peres,  1979; Huang,  1982; Hui,  1983). This 
would make it less distinguishable if it was not isolated from the rest of the current 
in cut fibers by the subtraction procedure used here. 
Nevertheless, it showed a 'hump' waveform and a steep voltage sensitivity both in 
the time to the peak stage (which was altered by 6 ms) and in the relative magnitude, 
which was comparable with changes in related parameters in A[Ca  2§  signals whose 
FIGURE 5.  Ca  2+ signals in the 
absence  of  tetracaine  com- 
pared with  tetracaine-sensitive  I  0.5  aM 
components  of charge  move-  I  O.I ~A/I~F 
ments (arrowed) in response to 
depolarizing  steps  in  5-mV 
increments  through  the  con- 
tractile  rheobase.  Fiber 
0318A: diameter,  110 #m; sar- 
comere spacing, 2.34 #m; tem- 
perature,  2.8~  and  antipy- 
L,50  J  ./,.~  ms  ~  :  :. 
,v  t  ￿9  k  ?.:  \ 
￿9 y  .\ 
I  I 
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threshold 
rylazo III concentrations, 442-580 #M.  Linear capacitances  before and after adding tetra- 
caine were 9.89 and 9.79 nF, respectively. Estimated voltage excursion for an e-fold change 
in peak A[Ca2+], 5.8 mV; in tetracaine-sensitive  charge, 7.3 mV. 608  THE  JOURNAL OF  GENERAL PHYSIOLOGY. VOLUME 92 ￿9 1988 
waveform followed that of the charging transient.  For example, e-fold factors for 
tetracaine-sensitive charge and peak A[Ca2+], determined within 5 mV on either side 
of the  contraction threshold,  were estimated at 7.8  _+  4.6  and 4.1  +  1.9  mV (cf., 
Maylie et al.,  1987),  respectively. This voltage dependence was considerably steeper 
than that for total charge. This suggests that the tetracaine-sensitive charge in cut 
fibers may be equivalent to the qv of intact muscle fibers. 
Time Course of Tetracaine-sensitive Charge in Cut Fibers 
Finally, closer comparisons of nonlinear charge and A[Ca  2+]  signals were made in 
response  to rheobase voltage steps where  the  kinetics of both would be relatively 
slow and easy to resolve. Records were the average of 24 optical and electrical traces 
obtained before the addition  of tetracaine,  and  36  traces were obtained after the 
FIGURE  6.  Comparison  of 
(A) the time course of changes  ., 
in myoplasmic [Ca  r§  with (B) 
heavily signal-averaged and fil- 
tered  (see  Methods)  q,  tran-  ~-- 
sients  and  (C)  corresponding 
charge  transfer.  Vertical  scale 
bar represents a charging cur- 
rent of 0.05 t~A/~F and a total 
charge  of  0.96  nC/tzF,  or  a 
A[Ca  ~+]  of  0.22  t~M. Inset 
(left):  comparison  of (a)  total 
f 
20 ms 
charge movement in the absence of local anesthetic with  (b) maximum tetracaine-sensitive 
current obtained by scaling (c) transient that was abolished by 200 #M tetracalne to the enve- 
lope (a). Vertical bar, 0.5 uA/#F; horizontal bar, 20 ms. Fiber 0320:  diameter, 97.5 ~m; sar- 
comere spacing,  2.36  #m;  temperature,  3.5~  antipyrylazo III concentrations,  545  #M. 
Linear capacitances at  the  beginning and end  of the  procedure were  7.39  and  7.37  nF, 
respectively.  Nonlinear charge in the first and last records in the run taken in the absence of 
tetracaine was 20.17 and 19.9 nC/~F, respectively.  When tetracaine was added, the first and 
last  values were  17.08  and  17.15  nC/t~F.  The  changes  through  each  run  thus  were  not 
> 1.3%. 
addition  of 200  #M  tetracaine.  Such  averaging was  intercalated  every  12  sweeps 
with  sets of 12  control  sweeps in  response to  -30-mV  steps from the  -100-mV 
holding  potential.  The  latter  checked  linear  fiber  capacitance  and  its  stability 
through  the  procedure.  This  was  necessary  in  view  of the  long  duration  of the 
experiment. Additionally, by averaging sweeps in sets of 12 it was possible to control 
for any drifts in quantities of nonlinear charge while data were being collected (see 
the  legend  of  Fig.  6).  If  transfers  of  tetracaine-sensitive  charge  resulted  from 
changes  in  myoplasmic [Ca2+],  they  should  lag the  antipyrylazo III signal.  Fig.  6 
compares records of (A) heavily averaged A[Ca  2+] transients with (B) the tetracaine- 
sensitive portion of the charge movement and (C) its integral. When all traces were 
normalized  to  their peak values,  A[Ca  ~+]  signals clearly followed rather  than pre- 
ceded either the nonlinear currents or the charge moved. This confirms an earlier CSERNOCH ET AL.  Differential Effects of Tetracaine  609 
report (Vergara and Caputo,  1983) and is not consistent with such charge move- 
ment being a response to myoplasmic [Ca  ~+] changes (but see Discussion). 
Finally, records of the time course of the different charging currents enabled us 
to make an estimate of the upper limit of tetracaine-sensitive charge at contractile 
threshold in addition to the lower limit provided earlier. Fig. 6 (inset) compares (a) 
total charge movement before adding local anesthetic with  (b) maximum possible 
tetracaine-sensitive  charge  movement  obtained  by  scaling  (c)  experimentally 
obtained transients abolished by 200 #M tetracaine to the envelope represented by 
a. The scaling factor obtained in six experiments suggested that the maximum tetra- 
caine-sensitive charge would not exceed 1.83  _+ 0.39 times the lower limit obtained 
here. 
DISCUSSION 
These experiments compared the effects of tetracaine on simultaneously measured 
charge movements, A[Ca  ~+] signals, and contractile threshold in cut amphibian skel- 
etal  muscle  fibers in which  antipyrylazo III was  introduced into the  intracellular 
space. 
Ca  ~+ signals, in particular the early A[Ca  2+] peak, were used to indicate changes in 
Ca  2+ release. This requires the properties of antipyrylazo III and of 'fast' cytosolic 
buffering to be not appreciably affected by tetracaine treatment (see Melzer et al., 
1986b). The first point has been checked by Vergara and Caputo (1983). We noted 
here that peak A[Ca  ~+] associated with barely visible contraction did not alter. This 
agrees  with  relationships  observed  earlier  between  contraction  and  either  peak 
A[Ca  2+] or the threshold of arsenazo III signals (Kovacs and Szucs, 1983; Miledi et 
al.,  1983).  It is  consistent with  an unchanged  distribution  between cytosolic-free, 
troponin-buffered, and other 'fast'-buffered Ca  2+ at least at a constant end-point of 
troponin  activation.  Alternative hypotheses would be considerably more complex 
and would not be consistent with earlier observations that tetracaine did not alter 
the pCa-tension relation in skinned fibers (Almers and Best, 1976). It is conceivable 
that changes in 'slow' Ca  ~+ buffering could influence the optical transients (Melzer 
et al.,  1986a). Decays of A[Ca  ~+] after the peak were sometimes more prolonged in 
tetracaine, and this could reflect reductions in Ca  2+ reuptake (e.g., Fig.  1, also see 
Bianchi and Bolton, 1967). However, the latter would affect A[Ca  ~+] in a direction 
opposite to the net changes observed here and allowing for such phenomena would 
merely reinforce our present conclusions. 
In  any  event,  A[Ca  2+]  measurements  offer a  more  direct  indication  of Ca  ~+ 
release than earlier measurements of tension generation (Almers and Best,  1976). 
Furthermore,  even  low  tetracaine  concentrations  (25-40  #M)  caused  large  (44- 
80%) reductions of A[Ca  ~+] signals with little effect on charge movements. It would 
be  difficult to disregard  such  changes  in  Ca  ~+  release when  accounting for such 
large effects. These findings,  therefore, suggest that low tetracaine concentrations 
could reduce Ca  ~+ release by the sarcoplasmic reticulum, and consequently suppress 
contraction without altering nonlinear charge. This explains earlier findings by Al- 
mers (1976; see Introduction) and the inhibition of caffeine contractures by tetra- 
caine (Luttgau and Oetliker, 1968). 
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voltages in intact fibers (Adrian and Huang,  1984a, b). However, the latter currents 
are frequently less prominent or indistinguishable in cut fibers (Adrian and Peres, 
1979; Melzer et al.,  1986b). High tetracaine concentrations that approached those 
used on intact fibers, were toxic to cut fibers (see also Lamb,  1986). Nevertheless, 
our lower limit for 'threshold' tetracaine-sensitive charge of 2.8 nC/#F did not alter 
appreciably between tetracaine concentrations of 100-200 #M. The voltage depen- 
dence of its time course and relative amounts suggested an equivalence to the 'q~' 
described in intact fibers. It is therefore possible that discrepancies between cut and 
intact preparations might reflect quantitative kinetic differences in particular com- 
ponents rather than the presence or absence of entire charge species. 
The  findings  under  the  higher  tetracaine  concentrations  are  consistent  with 
observations in hypertonic solutions where tetracaine abolished a  discrete, steeply 
voltage-dependent (q~) charge (Huang,  1981,  1982).  We were unable to maintain 
viable cut  (as  opposed  to intact)  fibers in  hypertonic solutions.  Nevertheless,  the 
finding that tetracaine acts both at Ca  2+ release and charge transfer sites to degrees 
that  depend differently on concentration, partly reconciles the earlier apparently 
conflicting findings. 
Tetracaine has been used when studying charge movements in mammalian mus- 
cle, which were thought not to alter with such treatment (e.g., Dulhunty and Gage, 
1983; Dulhunty et al., 1987). However, such results would be difficult to interpret if 
tetracaine not only abolished Ca  *+ release but also reduced part of the charge move- 
ment. Indeed, reported quantities of maximum charge in mammalian fibers varied 
by as  much as a  factor of two depending on the choice of external solution and 
whether tetracaine was present (see Hollingworth and Marshall, 1981; Hollingworth 
et al., 1987). A significant number of agents used on charge movements could have 
more than one site of action. Besides the local anesthetics studied here, the dihydro- 
pyridines D600 and nifedipine affect surface or transverse tubular Ca  ~+ channels in 
addition to excitation-contraction coupling (Hui et al., 1984; Rios and Brum, 1987). 
Nevertheless, these findings do not preclude the use of tetracaine or other agents 
that may have more than one site of action in empirical separations of charge move- 
ment components, provided that the concentrations used entirely abolish the com- 
ponent being isolated (e.g., Huang,  1981; Hui, 1983). 
Finally, the results exclude one possible hypothesis for the origin of the nonlinear 
charge.  It has frequently been suggested in the literature that some of the charge 
movement, particularly the delayed (q~) transients, is the consequence of changes in 
intracellular [Ca  2+] in excitation-contraction coupling (see Horowicz and Schneider, 
1981;  Huang,  1981;  Hui,  1983;  Caille  et  al.,  1985;  Lamb,  1986;  Melzer et  al., 
1986b; Dulhunty et al., 1987). For example, an increase in myoplasmic [Ca  2§  could 
cause  surface  (GouyoChapman)  charge  neutralization  on  the  cytoplasmic face of 
transverse tubular membrane through Ca  2+ binding (Aveyard and Haydon, 1973). 
This would shift transmembrane field in a direction that would cause additional and 
delayed charge movement following the time course of free A[Ca~+]. 
However, there have been relatively few attempts to test this kind of model. Yet, 
such hypotheses conveniently explain the entire tetracaine-sensitive charge, includ- 
such hypotheses conveniently explain the entire tetracaine-sensitive charge, includ- 
ing  delayed transients  otherwise difficult to  model,  simply  as  secondary  to  Ca  2+ CSERNOCH ET AL.  Differential Effects of Taracaine  611 
release.  They  also  explain  tetracaine  actions  on  both  Ca  2+  release and  nonlinear 
charge  through  a  single action at  sarcoplasmic reticular Ca  2§  release. This would 
also clarify the effect of tetracaine on caffeine contractures (Luttgau and Oetliker, 
1968).  However,  in our experiments, the A[Ca  2+]  signal followed rather than  pre- 
ceded charge transfer. Interpretation of such results must allow for the optical mea- 
surements representing an average A[Ca  ~+] along the sarcomere, rather than at the 
site of Ca  2+ release. However, the additional steady state findings contrasted an 80% 
reduction in peak A[Ca  2+] with the absence of major effects on charge movements. 
This was observed even when the lower limit for tetracaine-sensitive charge at con- 
traction threshold was -2.8  nC/#F, as was determined at high drug concentrations. 
This  greater  sensitivity of  A[Ca  9+]  signals  than  charge  movements  to  tetracaine, 
combined with the kinetic results, are clearly contrary to a hypothesis in which intra- 
cellular A[Ca  ~+] causes charge movement. 
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